On Tuesday, iBio Inc (NASDAQ: IBIO) opened lower -7.57% from the last session, before settling in for the closing price of $1.85. Price fluctuations for IBIO have ranged from $0.56 to $6.89 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 64.37% annually for the last half of the decade. Company’s average yearly earnings per share was noted 84.57% at the time writing. With a float of $19.70 million, this company’s outstanding shares have now reached $20.25 million.
iBio Inc (IBIO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of iBio Inc is 12.38%, while institutional ownership is 44.42%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.48 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.46) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.57% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.84% during the next five years compared to 64.37% growth over the previous five years of trading.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
Check out the current performance indicators for iBio Inc (IBIO). In the past quarter, the stock posted a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 76.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.1 million. That was inferior than the volume of 2.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.44%.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 35.35%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3698 in the past 14 days, which was higher than the 0.1566 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4904, while its 200-day Moving Average is $1.2538. However, in the short run, iBio Inc’s stock first resistance to watch stands at $1.7900. Second resistance stands at $1.8700. The third major resistance level sits at $1.9100. If the price goes on to break the first support level at $1.6700, it is likely to go to the next support level at $1.6300. The third support level lies at $1.5500 if the price breaches the second support level.
iBio Inc (NASDAQ: IBIO) Key Stats
There are currently 22,487K shares outstanding in the company with a market cap of 38.45 million. Presently, the company’s annual sales total 400 K according to its annual income of -18,380 K. Last quarter, the company’s sales amounted to 100 K and its income totaled -5,720 K.
